BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2184063)

  • 1. Insulin-driven erythropoiesis may underlie impairment of erythrocyte deformability in hyperinsulinaemic, hyperglycaemic ob/ob-mice.
    Engström KG; Grankvist K; Täljedal IB
    Diabetologia; 1990 Mar; 33(3):127-30. PubMed ID: 2184063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased deformability of erythrocytes in hyperglycaemic non-inbred ob/ob mice.
    Engström KG; Täljedal IB
    Diabetologia; 1986 Sep; 29(9):661-6. PubMed ID: 3792698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered shape and size of red blood cells in obese hyperglycaemic mice.
    Engström KG; Täljedal IB
    Acta Physiol Scand; 1987 Aug; 130(4):535-43. PubMed ID: 3630732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased size and biconcavity in red blood cells of obese-hyperglycaemic mice.
    Engström KG; Täljedal IB
    Biorheology; 1988; 25(4):625-38. PubMed ID: 3252917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of erythropoiesis by new methylene blue staining to establish reticulocyte maturity in bone marrow aspirates and peripheral blood.
    Inoue T; Tatsumi N
    Acta Cytol; 1991; 35(4):479-80. PubMed ID: 1927185
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathways of terminal erythrocyte differentiation in birds. An analysis of the intermediate forms].
    Kul'minskaia AS; Gazarian KG
    Ontogenez; 1976; 7(6):590-7. PubMed ID: 1028009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo studies on lipogenesis in obese hyperglycaemic (ob-ob) mice: possible role of hyperinsulinaemia.
    Loten EG; Rabinovitch A; Jeanrenaud B
    Diabetologia; 1974 Feb; 10(1):45-52. PubMed ID: 4275919
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice.
    Bailey CJ; Flatt PR; Atkins TW
    Int J Obes; 1982; 6(1):11-21. PubMed ID: 7040265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Kwasowski P; Swanston-Flatt SK; Marks V
    Diabetes; 1983 May; 32(5):433-5. PubMed ID: 6341126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon and diabetes: evidence for marked insensitivity to local regulation of A-cell function by endogenous insulin in obese-hyperglycaemic (ob/ob) mice [proceedings].
    Flatt PR; Buchanan KD; Bailey CJ
    Biochem Soc Trans; 1980 Feb; 8(1):58-9. PubMed ID: 6989672
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of aluminium on erythropoiesis, iron metabolism and some functional characteristics of erythrocytes in rats.
    Ganchev T; Dyankov E; Zacharieva R; Pachalieva I; Velikova M; Kavaldjieva B
    Acta Physiol Pharmacol Bulg; 1998; 23(1):27-31. PubMed ID: 10347617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of Deformation Properties of Erythrocytes in Wistar Rats during Postnatal Ontogeny.
    Katyukhin LN; Novozhilov AV
    Bull Exp Biol Med; 2021 Nov; 172(1):5-8. PubMed ID: 34792712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective loss of younger erythrocytes from blood circulation and changes in erythropoietic patterns in bone marrow and spleen in mouse anemia induced by poly-dispersed single-walled carbon nanotubes.
    Bhardwaj N; Saxena RK
    Nanotoxicology; 2015; 9(8):1032-40. PubMed ID: 25831400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma glucose and insulin response to glucagon and arginine in Aston ob/ob mice: evidence for a selective defect in glucose-mediated insulin release.
    Flatt PR; Bailey CJ
    Horm Metab Res; 1982 Mar; 14(3):127-30. PubMed ID: 7040198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
    Stevenson RW; Hutson NJ; Krupp MN; Volkmann RA; Holland GF; Eggler JF; Clark DA; McPherson RK; Hall KL; Danbury BH
    Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoiesis.
    Hillman RS; Finch CA
    N Engl J Med; 1971 Jul; 285(2):99-101. PubMed ID: 4933969
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin releasing effects of adrenocorticotropin (ACTH 1-39) and ACTH fragments (1-24 and 18-39) in lean and genetically obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Int J Obes; 1987; 11(2):175-81. PubMed ID: 3038765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma, erythrocyte, and platelet magnesium levels in normotensive and hypertensive obese subjects during oral glucose tolerance test.
    Corica F; Allegra A; Ientile R; Buemi M; Corsonello A; Bonanzinga S; Macaione S; Ceruso D
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):128-36. PubMed ID: 10090339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.